PRI-002 clinical trials

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

This study is testing a new drug, PRI-002, for people with early Alzheimer's disease or mild memory problems caused by Alzheimer's. Scientists hope PRI-002 can break down sticky substances in the brain thought to cause the disease, potentially slowing its effects.